Skip to main content

Stay Updated on Stockhausen – News and Insights

Masimo’s smartSET™ FDA Clearance Offers Breakthrough Innovation in Pulse Oximetry to Help Improve Critical Patient Outcomes

Industry-Leading Pulse Oximetry Platform Now Features First-of-Its-Kind Atrial Fibrillation (AFib) Detection with Previously Cleared AI-Enabled Opioid-Induced Respiratory Depression (OIRD) Detection Designed Together to Deliver Earlier Clinical InsightsIRVINE, Calif., Oct. 17, 2026 /PRNewswire/ — Masimo, a Danaher company and a…